CME Group Inc. (NASDAQ:CME) Shares Sold by Advisors Asset Management Inc.

Advisors Asset Management Inc. cut its stake in CME Group Inc. (NASDAQ:CME) by 17.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,424 shares of the financial services provider’s stock after selling 1,379 shares during the period. Advisors Asset Management Inc.’s holdings in CME Group were worth $1,417,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in CME. Ameriprise Financial Inc. boosted its position in shares of CME Group by 11.3% during the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after buying an additional 537,758 shares during the period. Raymond James & Associates raised its stake in CME Group by 3.2% during the 2nd quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock valued at $595,530,000 after acquiring an additional 94,302 shares in the last quarter. Legal & General Group Plc boosted its position in CME Group by 6.6% during the 2nd quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock worth $557,371,000 after acquiring an additional 176,004 shares during the period. PineStone Asset Management Inc. grew its stake in shares of CME Group by 137.6% in the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after purchasing an additional 1,309,097 shares in the last quarter. Finally, Rathbones Group PLC increased its holdings in shares of CME Group by 3.7% during the second quarter. Rathbones Group PLC now owns 1,311,474 shares of the financial services provider’s stock valued at $257,836,000 after purchasing an additional 46,276 shares during the period. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Up 0.1 %

Shares of NASDAQ:CME opened at $229.37 on Tuesday. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $230.74. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market cap of $82.66 billion, a PE ratio of 24.12, a price-to-earnings-growth ratio of 5.28 and a beta of 0.55. The firm has a 50 day simple moving average of $223.86 and a 200 day simple moving average of $211.19.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter last year, the firm posted $2.25 earnings per share. CME Group’s revenue was up 18.4% compared to the same quarter last year. As a group, research analysts expect that CME Group Inc. will post 10.22 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be paid a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 annualized dividend and a yield of 2.01%. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on CME shares. Morgan Stanley increased their target price on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research report on Thursday, October 17th. The Goldman Sachs Group increased their price objective on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a report on Thursday, October 3rd. Bank of America boosted their target price on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. Deutsche Bank Aktiengesellschaft lowered their price target on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Finally, Piper Sandler upped their price objective on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Monday, October 28th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, CME Group has an average rating of “Hold” and an average target price of $224.47.

Insider Activity

In related news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This trade represents a 12.01 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Sunil Cutinho sold 4,500 shares of the business’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total value of $1,019,880.00. Following the completion of the transaction, the insider now owns 27,053 shares in the company, valued at $6,131,291.92. This trade represents a 14.26 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock worth $3,441,063 in the last 90 days. Company insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.